True or false: Long-term studies are a valuable addition to the orthopaedic sports medicine literature. Forcing an orthopaedic surgeon to make such a stark binary choice risks oversimplifying a complex issue. In principle, long-term follow-up of our most common surgical procedures should provide information that would be of great value to our patients. Although our interventions can improve a patient's function and quality of life within months, weeks, or even days, they also seek to alter the natural history of conditions that may take decades to develop. To 18-year-old athletes focused on returning to competition as soon as possible, the chances of developing disabling gonarthrosis by age 45 may not be a pressing issue. To quote John Dryden, ''For present joys are more to flesh and blood/ than a dull prospect of a distant good.'' However, as the caregivers of these callow youth, we should certainly be concerned on their behalf.
Unfortunately, the prognostic capacity of long-term clinical studies is hampered by a litany of almost inevitable flaws. A substantial number of patients has frequently been lost to follow-up, which can seriously weaken a study's scientific validity. Extended follow-up often comes in the form of a surgeon's case series, so any comparison among alternatives is historical and indirect. Data-gathering methods and outcome assessment tools that are now considered indispensable may not have been available when the study was begun. The surgical technique that was deemed cutting-edge decades ago may today seem obsolete, causing us to question its relevance for today's surgeons. We think we've improved our methods over the years; what we'd really like to know is the long-term consequences of the procedures we're performing right now. As Tom Wright, the porter of my medical school dorm, once put it, ''Experience is a lousy teacher. It's always late coming to work!'' These caveats notwithstanding, I would assert that the correct answer to my initial question is, ''True.'' Longerterm studies give us the best available glimpse into the future ramifications of our surgical interventions. In this issue of the American Journal of Sports Medicine, several author groups provide us with follow-up on surgery they performed 1 or 2 decades ago. Two of these studies report the ability of autologous chondrocyte implantation (ACI) to restore knee function in patients with symptomatic articular cartilage defects, while another pair deal with the long-term outcomes of anterior cruciate ligament (ACL) reconstruction.
In A 20-Year Follow-up After First-Generation Autologous Chondrocyte Implantation, Ogura et al 17 update the status of some of the first North American patients to be treated with this method of articular cartilage resurfacing. All 23 patients (24 knees) operated on between June 1995 and July 1996 were followed for at least 20 years. Because the technique was new, the authors reserved it for the most recalcitrant problems, some of which would not be considered suitable for ACI today. The mean involved articular surface area was 11.8 cm 2 . Most patients had multiple lesions; 12 were considered complex cases, and 10 were classified as salvage. As a group, they had undergone 46 prior operations.
Over the ensuing 2 decades, 9 cases failed, for a graft survival rate of 63%. The 15 patients whose grafts survived generally maintained their symptomatic improvement during the follow-up period. Subsequent surgical procedures were common, especially during the first 5 postoperative years. The first-generation ACI technique used a periosteal graft that often hypertrophied and required debridement; partial graft delamination was also frequent. The authors' ability to track their entire cohort for 2 decades gives us a very complete picture of the capabilities and limitations of this resurfacing technique in challenging circumstances, although the case series design precludes directly comparing the results with those of other treatment options.
As is often the case with innovative procedures, the initial enthusiasm for ACI has been tempered by the documentation of the limitations of its therapeutic abilities, as demonstrated by other important studies. 5, 16, 19, 22 Longterm follow-up of cases performed by the technique's originators revealed a 92% satisfaction rate, with documentation indicating durable improvement, albeit to less-than-normal outcome scores. 22 A 10-year study, which included magnetic resonance imaging, reported an increase in mean Lysholm scores from 42 to 71 and a decrease in pain visual analog scores from 7.2 to 2.1 after first-generation ACI, although 78% of knees still exhibited defect-related bone marrow edema. 16 The findings of one randomized trial that compared ACI with mosaicplasty favored ACI, which had a failure rate of 17%, in contrast with 55% for mosaicplasty. 4 Another trial that randomized 80 patients between ACI and microfracture reported 17 failures in the ACI group and 13 in the microfracture group 15 years postoperatively. 14 The surviving patients from both groups noted persistent symptomatic improvement, although about half had radiographic signs of osteoarthritis. The authors concluded that neither technique appeared to prevent the development of post-traumatic arthritis to an acceptable degree.
Many candidates for articular cartilage resurfacing expressly desire to resume or continue participating in sports activities. In another study in this month's AJSM, Erdle et al 9 report the sports activity of 70 athletes over the first 11 years after first-generation ACI surgery. The good news is that 66% reported that their ability to participate in sports improved after the surgery, while only 13% felt that surgery was followed by a decline in their sports activity. The bad news: The percentage of patients participating in sports decreased from 96% before the onset of symptoms to 83% postoperatively, and those who did participate spent less time exercising and often switched to disciplines that placed less stress on their knees. Although they soldiered on, 86% of these patients reported experiencing some degree of pain during sports. Magnetic resonance imaging demonstrated a significant but weak correlation between the appearance of the repaired cartilage and the level of performance achieved.
These results echo those of a recent 5-year follow-up study of second-generation ACI that also showed a reduction in the volume of sports activity and a shift toward lower-impact options. 21 Paradoxically, return to sport after cartilage repair may be better in higher-level athletes. 28 Perhaps the greater levels of talent, motivation, and rehabilitation expertise available to such athletes increase the chances of a successful recovery. Other studies reinforce the notion that rigorous rehabilitation after ACI can improve the chances of a successful return to sport. 6, 8 After ACL rupture, the prospect of eventual arthritic degeneration is also a long-term concern. In the latest installment in their ongoing analysis of ACL reconstruction with autogenous patellar tendon grafts, Shelbourne et al 26 examined the factors associated with the development of osteoarthritis in 398 patients (423 knees) who had undergone surgery 20 or more years previously. Many of the parameters that were associated with osteoarthritis at the time of follow-up are not unexpected: medial or lateral meniscectomy, articular cartilage injury, and a history of multiple giving-way episodes before the index reconstruction. As these authors have a special interest in the effects of the loss of full extension on knee health, 27 they paid particular attention to this factor. They found that the absence of extension within 2°of the uninvolved knee at the time of follow-up increased the odds of osteoarthritis by 3.84. Because flexion contractures are a common feature of osteoarthritis, this may not seem too surprising. However, the authors also found that the presence of such a flexion contracture at the time of a patient's initial discharge from physical therapy was associated with a 2-fold increase in the odds of osteoarthritis at the time of long-term followup, implying that an unresolved postoperative loss of extension might contribute to the pathogenesis of osteoarthritis.
This study is not the first to investigate the prevalence of osteoarthritis in the decades after ACL injury and reconstruction. Like Shelbourne et al, Pinczewski has faithfully and meticulously followed his ACL patients over many years. 24, 29 In their recent 20-year follow-up study, 29 his group reported a 41% prevalence of osteoarthritis in patients who had received hamstring grafts and a significantly greater prevalence of 61% after patellar tendon grafting. Other long-term studies of ACL reconstruction have reported a prevalence of osteoarthritis ranging from 20% to 42% at 10 years 1, 13 to 42% at 20 years 23 and 54% at 24 years. 20 Factors that have been associated with an increased risk of developing arthritis in these other studies include accompanying meniscus or articular cartilage injury, 20,23 patient age, 20 and greater time from injury to reconstruction. 20 While reconstruction has been reported by some to reduce the risk of osteoarthritis after ACL injury, 1, 15, 25 it clearly does not eliminate it.
The possibility of augmenting or replacing the injured ACL with a synthetic construct has generated periodic cycles of hope and disappointment among knee surgeons. In an article likely to provoke discussion and even controversy, Chen et al 7 compare their 10-year results of synthetic reconstruction with remnant preservation to those after reconstruction with a hamstring autograft. The presence of a good-quality ACL remnant was a prerequisite for use of the synthetic Ligament Augmentation Reinforcement System; otherwise, the ACL was reconstructed with a 4stranded hamstring graft. The authors obtained subjective follow-up on 38 of 43 patients who received synthetic grafts and 73 of 90 who underwent hamstring reconstruction. In addition, physical and radiographic examinations were performed for 35 of the synthetic cases and 69 of the hamstring autografts. Both groups of patients demonstrated a failure rate of about 8%, with similar Kaplan-Meier survival curves. Although the synthetic group generated slightly higher outcome scores in the first 6 to 12 months after surgery, there was no significant difference between the 2 techniques at 5 and 10 years. As in other ACL reconstruction reports, radiographic signs of arthritis were common, detected in about half of each treatment group.
As these authors note, synthetic ACL substitutes have historically had unacceptably high failure rates. The specific device that they used has generated acceptance among some surgeons 2,3,10,18,32 but also several unfavorable reports of frequent failures 12, 30, 33 and sporadic cases of intense synovitis 10, 11, 32 or foreign-body reaction. 31 The current authors attribute their success with the synthetic device to the strict requirement for remnant preservation and careful attention to tunnel positioning. Because this study demonstrated generally equivalent performance for synthetic and autograft ACL reconstruction, it may not produce many converts from autografts to the use of synthetic ligament substitutes, but it should provide guidance for surgeons who already use them or who would consider doing so for situations in which autograft options are compromised and allografts may not be available.
Helping patients accomplish short-term goals like eliminating pain, restoring stability, regaining function, and returning to competition is a source of tremendous satisfaction for orthopaedic surgeons. Unless we're among the few practitioners who systematically follow their patients for periods that stretch into decades, it is much more difficult to appreciate the long-term outcomes of our interventions. That is, until one winter evening when a vaguely familiar middle-aged spectator approaches us on the basketball court at half-time. As the stranger begins to speak, the years fade away to reveal a 20-year-old college athlete. ''You may not remember me, doc, but you did my ACL 25 years ago, when I was on the team. I just wanted you to know that my knee is doing great; I still play ball with my kids twice a week.'' We share a hug and turn our attention back to the game at hand, yet savoring the deep inner warmth that tells us we chose the right calling. As a profession, we are indebted to the investigators who are willing to put in the dogged, disciplined effort required to conduct long-term clinical research. The evidence they accumulate, despite its limitations, may help us to experience more of those magical moments.
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